TY - JOUR
T1 - Expanded terminal sedation in end-of-life care
AU - Gilbertson, Laura
AU - Savulescu, Julian
AU - Oakley, Justin
AU - Wilkinson, Dominic
N1 - Funding Information:
This study was funded by Wellcome (WT203132) and Wellcome Trust (WT203132).
Publisher Copyright:
© 2023 BMJ Publishing Group. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Despite advances in palliative care, some patients still suffer significantly at the end of life. Terminal Sedation (TS) refers to the use of sedatives in dying patients until the point of death. The following limits are commonly applied: (1) symptoms should be refractory, (2) sedatives should be administered proportionally to symptoms and (3) the patient should be imminently dying. The term 'Expanded TS' (ETS) can be used to describe the use of sedation at the end of life outside one or more of these limits. In this paper, we explore and defend ETS, focusing on jurisdictions where assisted dying is lawful. We argue that ETS is morally permissible: (1) in cases of non-refractory suffering where earlier treatments are likely to fail, (2) where gradual sedation is likely to be ineffective or where unconsciousness is a clinically desirable outcome, (3) where the patient meets all criteria for assisted dying or (4) where the patient has greater than 2 weeks to live, is suffering intolerably, and sedation is considered to be the next best treatment option for their suffering. While remaining two distinct practices, there is scope for some convergence between the criteria for assisted dying and the criteria for ETS. Dying patients who are currently ineligible for TS, or even assisted dying, should not be left to suffer. ETS provides one means to bridge this gap.
AB - Despite advances in palliative care, some patients still suffer significantly at the end of life. Terminal Sedation (TS) refers to the use of sedatives in dying patients until the point of death. The following limits are commonly applied: (1) symptoms should be refractory, (2) sedatives should be administered proportionally to symptoms and (3) the patient should be imminently dying. The term 'Expanded TS' (ETS) can be used to describe the use of sedation at the end of life outside one or more of these limits. In this paper, we explore and defend ETS, focusing on jurisdictions where assisted dying is lawful. We argue that ETS is morally permissible: (1) in cases of non-refractory suffering where earlier treatments are likely to fail, (2) where gradual sedation is likely to be ineffective or where unconsciousness is a clinically desirable outcome, (3) where the patient meets all criteria for assisted dying or (4) where the patient has greater than 2 weeks to live, is suffering intolerably, and sedation is considered to be the next best treatment option for their suffering. While remaining two distinct practices, there is scope for some convergence between the criteria for assisted dying and the criteria for ETS. Dying patients who are currently ineligible for TS, or even assisted dying, should not be left to suffer. ETS provides one means to bridge this gap.
KW - Euthanasia
KW - Pain Management
KW - Palliative Care
KW - Right to Die
KW - Terminal Care
UR - http://www.scopus.com/inward/record.url?scp=85148664626&partnerID=8YFLogxK
U2 - 10.1136/jme-2022-108511
DO - 10.1136/jme-2022-108511
M3 - Article
C2 - 36543531
AN - SCOPUS:85148664626
SN - 0306-6800
VL - 49
SP - 252
EP - 260
JO - Journal of Medical Ethics
JF - Journal of Medical Ethics
IS - 4
ER -